This phase II trial studies how anxiety is affected by 2 types of follow-up after surgery, limited follow-up and intense follow-up, in patients with stage II-III soft tissue sarcoma of the trunk and extremities. In cancer survivors, the fear of cancer coming back (recurring) is common and may persist long after the end of treatment. It may also be exacerbated by return visits for imaging (surveillance). The purpose of this study is to determine how patients' anxiety and other cancer-related outcomes are affected by how often surveillance is done.
Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC V8, Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC V8, Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC V8, Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC V8
This phase II trial studies how anxiety is affected by 2 types of follow-up after surgery, limited follow-up and intense follow-up, in patients with stage II-III soft tissue sarcoma of the trunk and extremities. In cancer survivors, the fear of cancer coming back (recurring) is common and may persist long after the end of treatment. It may also be exacerbated by return visits for imaging (surveillance). The purpose of this study is to determine how patients' anxiety and other cancer-related outcomes are affected by how often surveillance is done.
Evaluating the Impact of Limited Compared with Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients with Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities
-
M D Anderson Cancer Center, Houston, Texas, United States, 77030
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
M.D. Anderson Cancer Center,
Christina L Roland, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center
2024-12-31